Clinical reference Biomarker Directory
Back to directory

CST3

Established

Cystatin C is a kidney function marker now central to the 2021 race-free eGFR equations.

Also known as Cystatin C
In plain language

Cystatin C is a protein that helps measure kidney function more fairly than the older creatinine-only test, especially since 2021 when kidney doctors updated the formula to remove a race-based adjustment that wasn't scientifically justified.

Biomarker & context

CST3 encodes cystatin C, a protein filtered by the kidneys at a constant rate regardless of muscle mass, making it a more reliable kidney function marker than creatinine in certain populations (e.g., very muscular or very frail patients).

What it indicates

Elevated cystatin C indicates reduced kidney filtration (glomerular filtration rate); it is now central to modern kidney function estimation equations, especially valued for reducing bias introduced by creatinine's dependence on muscle mass.

Diagnosis & clinical testing

Cystatin C is now central to the 2021 CKD-EPI race-free kidney function equations, which replaced the older creatinine-only formula that included a race coefficient — a change driven by the recognition that race is a social, not biological, construct. Combined creatinine + cystatin C equations are preferred over creatinine alone, especially near clinically important decision thresholds like transplant eligibility or drug dosing.

Guiding treatment

Cystatin C-based eGFR is particularly recommended for confirming borderline kidney function results and in populations where creatinine may be unreliable (extremes of muscle mass, amputees, malnourished patients).

Clinical significance

Reduces bias from muscle-mass dependence seen with creatinine; part of a major 2021 health-equity-driven guideline change.

References
  1. NIDDK. eGFR Equations for Adults.
  2. PMC. (2024). The 2021 CKD-EPI Race-Free eGFR Equations in Kidney Disease: Leading the Way in Ending Disparities.